HITI — High Tide Inc. Stock Price, Chart & AI Report

Neutral Jan 26, 2026 • 19:47 UTC Benzinga • Piero Cingari

Earnings Volatility Watch: These 10 Stocks Could Swing 30% Or More This Week

Options markets are pricing in elevated post-earnings volatility for 10 stocks reporting this week, with implied moves of 30% or more. The list is dominated by regional banks, with Capitol Federal Financial topping the list. The Federal Reserve's policy decision on Wednesday is expected to magnify price swings.

CFFN BBT HITI FRST earnings volatility implied moves regional banks Federal Reserve

Sentiment note

Only non-bank on the volatility list with 30%+ implied move, suggesting elevated uncertainty around earnings

Positive Sep 26, 2025 • 15:30 UTC Benzinga • Prnewswire

High Tide Makes ROB Annual Ranking of Canada's Top Growing Companies for Fifth Consecutive Year

High Tide Inc. ranked 182nd out of 400 companies in the 2025 Report on Business ranking of Canada's Top Growing Companies, with a three-year revenue growth rate of 188%. The company celebrated its fifth consecutive year of recognition and highlighted its recent majority acquisition of Remexian in the European cannabis market.

HITI cannabis retail growth ranking expansion

Sentiment note

Achieved fifth consecutive ranking in Top Growing Companies, demonstrated consistent revenue growth, expanded into European market, and maintained strong market position in cannabis retail

Positive Aug 20, 2025 • 12:00 UTC Benzinga • Prnewswire

High Tide to Open Two New Canna Cabana Locations Across Saskatchewan and Ontario

High Tide Inc. announced the opening of two new Canna Cabana cannabis retail stores in Saskatoon, Saskatchewan and Lasalle, Ontario, expanding their total store count to 205 locations across Canada.

HITI cannabis retail expansion Canna Cabana Saskatchewan Ontario

Sentiment note

Company is expanding its retail presence, opening two new stores in strategic locations with growth potential, and expressing confidence in achieving 2025 targets with potential international market entry

Positive Jan 29, 2025 • 22:42 UTC Benzinga • Adam Eckert

High Tide Q4 Earnings: Revenue Beat, EPS Miss, Positive Free Cash Flow, Accelerating Membership Growth And More

High Tide reported Q4 revenue of CA$138.3 million, beating estimates, but missed on EPS. The company saw accelerating growth in its membership program and generated positive free cash flow. High Tide expects to remain free cash flow positive for the rest of the fiscal year.

HITI High Tide earnings revenue EPS free cash flow membership growth

Sentiment note

The company reported a revenue beat, positive free cash flow, and accelerating membership growth, indicating strong operational performance.

Positive Jan 17, 2025 • 18:31 UTC Benzinga • Javier Hasse

This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More

The cannabis industry faces regulatory challenges, including delays in the DEA's reclassification process and scrutiny over enforcement strategies. However, there are also positive developments, such as declines in teen marijuana use in legal states and advancements in medical cannabis research and product innovation.

HITI PM cannabis reclassification DEA Biden's clemency Philip Morris Avicanna High Tide

Sentiment note

High Tide acquired a stake in a German cannabis company, positioning the company to capitalize on the growing European medical cannabis market.

Neutral Jul 12, 2024 • 21:26 UTC Benzinga • Jelena Martinovic

Latest Cannabis Hires And Board Changes, Here's What You Need To Know - Benzinga

The article discusses the latest leadership changes in the cannabis industry, including new hires and board appointments at EnWave Corporation, Virpax Pharmaceuticals, Cresco Labs, Avicanna, and High Tide.

VRPX HITI cannabis leadership changes hires board appointments

Sentiment note

The company held its annual general meeting, where shareholders elected directors, which is a routine corporate event.

Unknown Jun 18, 2024 • 13:40 UTC Zacks Investment Research • Zacks Equity Research

Is aTyr Pharma (ATYR) Outperforming Other Medical Stocks This Year?

Here is how Atyr Pharma (ATYR) and High Tide Inc. (HITI) have performed compared to their sector so far this year.

ATYR HITI

Unknown Jun 14, 2024 • 05:59 UTC Seeking Alpha • Caffital Research

High Tide: Higher Margins Are Now The Base Scenario

High Tide reported Q2 results, showing slow growth, explained by underlying weaker industry sales. Learn why HITI stock is a Buy.

HITI

Unknown Jun 13, 2024 • 21:35 UTC Zacks Investment Research • Zacks Equity Research

High Tide Inc. (HITI) Reports Break-Even Earnings for Q2

High Tide (HITI) delivered earnings and revenue surprises of 100% and 2.73%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

HITI ACB

Unknown Jun 7, 2024 • 13:30 UTC Zacks Investment Research • Zacks Equity Research

Wall Street Analysts Think High Tide (HITI) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for High Tide (HITI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

HITI

Unknown Jun 4, 2024 • 21:45 UTC Zacks Investment Research • Zacks Equity Research

High Tide Inc. (HITI) Outpaces Stock Market Gains: What You Should Know

High Tide Inc. (HITI) reachead $2.54 at the closing of the latest trading day, reflecting a +0.4% change compared to its last close.

HITI

Unknown Jun 3, 2024 • 21:15 UTC Zacks Investment Research • Zacks Equity Research

HealthEquity (HQY) Tops Q1 Earnings and Revenue Estimates

HealthEquity (HQY) delivered earnings and revenue surprises of 21.21% and 3.16%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

HQY HITI